Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs

Marc G. Ghany, MD, MHSc* **

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Kristen M. Marks, MD

Personal Financial Relationships: None

Institutional Research: Dr. Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc.

Updated: 11/12/2019

Timothy R. Morgan, MD

Personal Financial Relationships: None

Institutional Research: Dr. Morgan was awarded research grants, paid to his institution, from AbbVie Inc., Genfit, Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 11/12/2019

David L. Wyles, MD

Personal Financial Relationships: None

Institutional Research: Dr. Wyles was awarded research grants, paid to his institution, from Gilead Sciences Inc.

Updated: 11/12/2019

Current Panel Members

Andrew I. Aronsohn, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Debika Bhattacharya, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Tina Broder, MSW, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Jordan J. Feld, MD, MPH

Personal Financial Relationships: Dr. Feld serves as a scientific consultant to AbbVie, Inc., Arbutus Biopharma, Enanta, Merck & Co Inc, Gilead Sciences Inc. and Roche.

Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie Inc., Gilead Sciences, Inc, Janssen and Wako.

Updated: 11/12/2019

Stuart C. Gordon, MD

Personal Financial Relationships: Dr. Gordon serves on scientific advisory boards for AbbVie and Gilead Sciences, Inc.

Institutional Research: Dr. Gordon was awarded research grants, paid to his institution, from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 11/12/2019

Theo Heller, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Ravi Jhaveri MD, FIDSA, FPIDS, FAAP

Personal Financial Relationships: Dr. Jhaveri serves as a scientific consultant for MedImmune/AstraZeneca.

Institutional Research: Dr. Jhaveri received research grants, paid to his institution, from AbbVie, Inc., and Gilead Sciences, Inc.

Updated: 11/12/2019

Maureen M. Jonas, MD

Personal Financial Relationships: Dr. Jonas serves as a scientific consultant to Gilead Sciences, Inc. Pediatric HCV Advisory Board.

Institutional Research: Dr. Jonas was awarded research grants, paid to her institution, from AbbVie, Inc., Gilead Sciences, Inc, Merck & Co, Inc, and Roche.

Updated: 11/12/2019

Jennifer J. Kiser, PharmD, PhD

Personal Financial Relationships: None

Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from ViiV Healthcare, and Gilead Sciences.

Updated: 11/12/2019

Benjamin P. Linas, MD, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Vincent Lo Re, MD, MSCE

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

K. Rajender Reddy, MD

Personal Financial Relationships: Dr. Reddy serves on advisory boards for AbbVie, Inc., Gilead Sciences, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.

Institutional Research: Dr. Reddy was awarded research grants, paid to his institution, from AbbVie, Inc., Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck.

Updated: 11/12/2019

Andrew Reynolds

Personal Financial Relationships: None

Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Inc., and Gilead Sciences, Inc.

Updated: 11/12/2019

John D. Scott, MD, MSc, FIDSA

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Gloria Searson, ACSW

Personal Financial Relationships: None

Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 11/12/2019

Philip Spradling, MD **+

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Norah A. Terrault, MD

Personal Financial Relationships: Dr. Terrault serves on the medical affairs board of Gilead Sciences, Inc (uncompensated) and the advisory board of Intercept.

Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from Gilead Sciences, Inc.

Updated: 11/12/2019

Elizabeth C. Verna, MD, MS

Personal Financial Relationships: Dr. Verna serves on an advisory board of Gilead Sciences, Inc.

Institutional Research: Dr. Verna was awarded research grants paid to her institution from Salix Pharmaceuticals.

Updated: 11/12/2019

John B. Wong, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/12/2019

Ann E. Woolley, MD, MPH

Personal Financial Relationships: Dr. Woolley serves on the advisory board of Abbott.

Institutional Research: None

Updated: 09/26/2019

Kim Workowski, MD

Personal Financial Relationships: None

Institutional Research: Dr. Workowski was awarded research grants, paid to her institution, from Gilead Sciences, Inc.

Updated: 11/18/2019